Literature DB >> 27545142

Drug-induced hair colour changes.

Francesco Ricci1, Clara De Simone1, Laura Del Regno1, Ketty Peris1.   

Abstract

Hair colour modifications comprise lightening/greying, darkening, or even a complete hair colour change, which may involve the scalp and/or all body hair. Systemic medications may cause hair loss or hypertrichosis, while hair colour change is an uncommon adverse effect. The rapidly increasing use of new target therapies will make the observation of these side effects more frequent. A clear relationship between drug intake and hair colour modification may be difficult to demonstrate and the underlying mechanisms of hair changes are often unknown. To assess whether a side effect is determined by a specific drug, different algorithms or scores (e.g. Naranjo, Karch, Kramer, and Begaud) have been developed. The knowledge of previous similar reports on drug reactions is a key point of most algorithms, therefore all adverse events should be recognised and reported to the scientific community. Furthermore, even if hair colour change is not a life-threatening side effect, it is of deep concern for patient's quality of life and adherence to treatment. We performed a review of the literature on systemic drugs which may induce changes in hair colour.

Entities:  

Keywords:  drug; hair colour changes; hair depigmentation; hair hyperpigmentation

Mesh:

Substances:

Year:  2016        PMID: 27545142     DOI: 10.1684/ejd.2016.2844

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  6 in total

1.  Mimicking Natural Human Hair Pigmentation with Synthetic Melanin.

Authors:  Claudia Battistella; Naneki C McCallum; Karthikeyan Gnanasekaran; Xuhao Zhou; Valeria Caponetti; Marco Montalti; Nathan C Gianneschi
Journal:  ACS Cent Sci       Date:  2020-04-29       Impact factor: 14.553

2.  Repigmentation and new growth of hairs after anti-interleukin-17 therapy with secukinumab for psoriasis.

Authors:  Franco Rongioletti; Cristina Mugheddu; Severino Murgia
Journal:  JAAD Case Rep       Date:  2018-05-07

3.  Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.

Authors:  Brooke Benner; Logan Good; Dionisia Quiroga; Thomas E Schultz; Mahmoud Kassem; William E Carson; Mathew A Cherian; Sagar Sardesai; Robert Wesolowski
Journal:  Drug Des Devel Ther       Date:  2020-05-04       Impact factor: 4.162

4.  Hair Graying Regulators Beyond Hair Follicle.

Authors:  Jing Chen; Yixin Zheng; Chen Hu; Xuexiao Jin; Xiaoping Chen; Ying Xiao; Chaochen Wang
Journal:  Front Physiol       Date:  2022-02-24       Impact factor: 4.566

5.  Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.

Authors:  Diego Alvarado; Marcus Maurer; Richard Gedrich; Scott B Seibel; Michael B Murphy; Linda Crew; Joel Goldstein; Andrea Crocker; Laura A Vitale; Pamela A Morani; Lawrence J Thomas; Thomas R Hawthorne; Tibor Keler; Diane Young; Elizabeth Crowley; Martin Kankam; Margo Heath-Chiozzi
Journal:  Allergy       Date:  2022-03-03       Impact factor: 14.710

6.  Quantitative mapping of human hair greying and reversal in relation to life stress.

Authors:  Ayelet M Rosenberg; Shannon Rausser; Junting Ren; Eugene V Mosharov; Gabriel Sturm; R Todd Ogden; Purvi Patel; Rajesh Kumar Soni; Clay Lacefield; Desmond J Tobin; Ralf Paus; Martin Picard
Journal:  Elife       Date:  2021-06-22       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.